Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hailong Mi"'
Publikováno v:
Cell Cycle
Breast cancer remains a general-threat event in the health of women. Currently, increasing records indicate that long non-coding RNA maternally expressed 3 (MEG3) plays a central role in breast cancer. The current research focused on the function of
Autor:
Yuanting Gu, Xiaochun Wang, Nan Wang, Youyi Xiong, Fang Wang, Hailong Mi, Lin Li, Mingzhi Zhu
Publikováno v:
OncoTargets and Therapy. 13:657-666
Background Increasing evidence implies the participation of long non-coding RNAs (lncRNAs) in chemoresistance to cancer treatment. Their role and molecular mechanisms in breast cancer chemoresistance, nevertheless, are yet not considerably elucidated
Autor:
Hailong Mi, Nan Wang, Yuanting Gu, Fang Wang, Pengwei Lv, Lin Li, Mingzhi Zhu, Mingti Fu, Youyi Xiong, Chaochao Zhong
Publikováno v:
OncoTargets and Therapy. 12:10671-10679
Introduction Long non-coding RNAs (lncRNAs) were found to regulate many biological processes including cancer development, immunology and other diseases. LncRNA HULC was found to be oncogenes in many cancer progression. However, the role of HULC in t
Autor:
Youyi Xiong, Hailong Mi, Nan Wang, Fang Wang, Lin Li, Mingzhi Zhu, Xiaochun Wang, Yuanting Gu
Publikováno v:
European Journal of Pharmacology. 839:66-75
The emergence of drug resistance is still a daunting challenge for the effective therapy of cancer patients. miRNAs have been elucidated as an important regulator in chemoresistance of anti-cancer drugs. miR-381 is found to exert tumor-suppressive ef
Publikováno v:
Journal of cellular physiology. 234(8)
Breast cancer is a one of the most malignant threats among women worldwide. However, the mechanism underlying breast cancer development remains unclear. Long noncoding RNAs (lncRNAs) have been reported to participate in breast cancer. Whether lncRNA